Thomas Lougran headshot
TL

Thomas P. Loughran

Professor
Unit: School of Medicine
Department: Department of Medicine, Hematology and Oncology
Office location and address
Emily Couric Clinical Cancer Center
1335 Lee St
Charlottesville, Virginia 22903
Education
MD, Hahnemann Medical College
Clinical Fellowship, Oncology, Fred Hutchinson Cancer Research Center
Residency, Thomas Jefferson University Hospital, Philadelphia, PA
Biography

Thomas P. Loughran, Jr., MD, is the director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine. From July 2003 to August 2013, he served as the founding director of the Penn State Hershey Cancer Institute and Professor of Medicine at the Penn State College of Medicine. He previously served as program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center, and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, N.Y. He completed his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center under direction of Nobel Laureate, Dr. E.D. Thomas and remained on faculty there for seven years.

His career as a physician scientist is a testament to translational research beginning with his discovery of large granular lymphocyte (LGL) leukemia. He has published numerous articles in high impact peer-reviewed journals including The New England Journal of Medicine, Annals of Internal Medicine, Lancet, Journal of Clinical Investigation, Journal of Clinical Oncology, and Blood. He and his wife, Kenna, have two daughters, Kathleen and Kelly.

MD-CANC Cancer Clinical Trials Affiliation Agreement
Source: Riverside Healthcare Association, Inc.
August 18, 2015 – August 17, 2025
Targeted Sphingolipid Metabolism for Treatment of AML
Source: U.S. NIH Cancer Institute
June 01, 2020 – May 31, 2025
Integrative network modeling of regulatory modules in Large Granular Lymphocyte Leukemia
Source: U.S. NIH Cancer Institute
July 01, 2018 – June 30, 2022
Every Women's Life Program Renewal 2021-2022
Source: Virginia Department Of Health
June 30, 2021 – June 29, 2022
MD-CANC Cancer Center Support Grant
Source: U.S. NIH Cancer Institute
February 01, 2017 – January 31, 2022
Virginia Kincaid Cancer Research Fund
Source: Virginia Kincaid Charitable Trust
October 01, 2005 – December 31, 2021
American Cancer Society - 2021 Patient Transportation Grant
Source: American Cancer Society
August 31, 2021 – December 31, 2021
MD-INMD-HO-TPL Genomic Architecture of LGL Leukemia
Source: U.S. NIH Cancer Institute
December 01, 2015 – November 30, 2021
Orien Avatar Participation
Source: Moffitt Genetics Corporation
October 12, 2016 – October 11, 2021
Every Women's Life Program Renewal 2020-2021
Source: Virginia Department Of Health
June 30, 2020 – June 29, 2021
NCTN High Performance Site Initiative
Source: PPD Development, Inc.
November 01, 2017 – December 31, 2020
Virginia Kincaid Cancer Research Fund
Source: Virginia Kincaid Charitable Trust
November 10, 2017 – December 31, 2020
MD-CANC Every Women's Life Program Renewal 2019-2020
Source: Virginia Department Of Health
June 30, 2019 – June 29, 2020
MD-INMD-HO Targeted Sphingolipid Metabolism for Treatment of AML
Source: U.S. NIH Cancer Institute
September 18, 2015 – August 31, 2019
MD-CANC Every Women's Life Program Renewal 2018-2019
Source: Virginia Department Of Health
June 30, 2018 – June 29, 2019
MD-CANC Improving Working Women's Health in the Tobacco Region Using Telemedicine
Source: Virginia Tobacco Region Revitalization Commission
October 01, 2013 – September 30, 2018
Every Women's Life Program Renewal 2017-2018
Source: Virginia Department Of Health
June 30, 2017 – June 29, 2018
MD-INMD Survival Mechanisms in Leukemic NK Cells
Source: U.S. NIH Cancer Institute
June 12, 2014 – April 30, 2018
MD-INMD Targeting JAK/STAT and NF-kB Pathways in LGL Leukemia
Source: Leukemia & Lymphoma Society
October 01, 2013 – September 30, 2017
Cancer Center Without Walls: Increasing access tot he benefits of cancer research and advanced cancer care in Southwest Virginia
Source: Virginia Tobacco Region Revitalization Commission
September 27, 2012 – September 30, 2017
MD-CANCER Every Women's Life Program Renewal 2016-2017
Source: Virginia Department Of Health
June 30, 2016 – June 29, 2017
MD-CANC Cancer Center Support Grant - Year 25
Source: U.S. NIH Cancer Institute
June 05, 2012 – January 31, 2017
MD-INMD Characterizaiton of the LGL Leukemia Virus (PQ-12)
Source: U.S. NIH Cancer Institute
September 01, 2013 – August 31, 2016
MD-CANC Every Women's Life Program Renewal 2015-2016
Source: Virginia Department Of Health
June 30, 2015 – June 29, 2016
MD-INMD Elucidating Viral Tumor Antigen Reactivity in LGL Leukemia With and Without Rheumatoid Arthritis
Source: Sigma Xi
May 01, 2015 – May 31, 2016
Cancer Center Support Grant - Year 21
Source: U.S. NIH Cancer Institute
June 05, 2012 – January 31, 2016
Commonwealth Foundation for Cancer Research
Source: Commonwealth Cancer Foundation for Research
June 01, 2002 – December 31, 2015
MD-INMD-HO Network Modeling of Epithelial Mesenchymal Transition in Liver Cancer Metastasis
Source: Pennsylvania State University, The
December 01, 2014 – November 30, 2015
MD-INMD Targeted Sphingolipid Metabolism for Treatment of AML
Source: Pennsylvania State University, The
September 01, 2014 – August 31, 2015
MD-CANC Every Women's Life Program Renewal 2014-2015
Source: Virginia Department Of Health
June 30, 2014 – June 29, 2015
MD-INMD Network modeling of epithelial mesenchymal tranitions in liver cancer metastasis
Source: Pennsylvania State University, The
December 01, 2013 – November 30, 2014
MD-INMD Targeting Acid Ceramidase in AML
Source: Pennsylvania State University, The
September 10, 2013 – August 31, 2014
BIOC 9995: Topical Research: Biochemistry and Molecular Genetics
Credits: 3–12
Topical Research
PATH 9995: Topical Research
Credits: 1–12
Original research on approved problems.
MICR 9995: Research in Microbiology, Immunology and Infectious Diseases
Credits: 1–12
Research in microbiological related disciplines, e.g. cancer, immunology, bacteriology, virology, infectious diseases, cell signaling, nuclear transport, host-pathogen interactions, gene expression, etc.
BIOC 9998: Non-Topical Research: Preparation for Doctoral Research
Credits: 1–12
Non-Topical Research: Preparation for Doctoral Research
MICR 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.
BIOC 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.
PATH 9999: Non-Topical Research
Credits: 1–12
Dissertation research credit for students who have completed their advancement to candidacy.
BME 9999: Dissertation
Credits: 1–12
Formal record of student commitment to doctoral research under the guidance of a faculty advisor. May be repeated as necessary.
  • 2015-2018 Best Doctors in America® List